| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Prelude Therapeutics Incorporated (NASDAQ: PRLD)
PRLD Technical Analysis
5
| As on 9th Jun 2023 PRLD STOCK Price closed @ 5.42 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.30 & Strong Sell for SHORT-TERM with Stoploss of 10.39 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PRLDSTOCK Price
| Open | 5.53 | Change | Price | % |
| High | 5.66 | 1 Day | -0.12 | -2.17 |
| Low | 5.38 | 1 Week | -0.11 | -1.99 |
| Close | 5.42 | 1 Month | -0.45 | -7.67 |
| Volume | 45306 | 1 Year | -8.28 | -60.44 |
| 52 Week High 13.73 | 52 Week Low 4.00 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PRLD Daily Charts |
PRLD Intraday Charts |
Whats New @ Bazaartrend |
PRLD Free Analysis |
|
|
PRLD Important Levels Intraday
| RESISTANCE | 5.96 |
| RESISTANCE | 5.79 |
| RESISTANCE | 5.68 |
| RESISTANCE | 5.57 |
| SUPPORT | 5.27 |
| SUPPORT | 5.16 |
| SUPPORT | 5.05 |
| SUPPORT | 4.88 |
PRLD Forecast April 2024
| 4th UP Forecast | 10.72 |
| 3rd UP Forecast | 9.02 |
| 2nd UP Forecast | 7.97 |
| 1st UP Forecast | 6.92 |
| 1st DOWN Forecast | 3.92 |
| 2nd DOWN Forecast | 2.87 |
| 3rd DOWN Forecast | 1.82 |
| 4th DOWN Forecast | 0.12 |
PRLD Weekly Forecast
| 4th UP Forecast | 9.33 |
| 3rd UP Forecast | 8.08 |
| 2nd UP Forecast | 7.30 |
| 1st UP Forecast | 6.53 |
| 1st DOWN Forecast | 4.31 |
| 2nd DOWN Forecast | 3.54 |
| 3rd DOWN Forecast | 2.76 |
| 4th DOWN Forecast | 1.51 |
PRLD Forecast2024
| 4th UP Forecast | 26.46 |
| 3rd UP Forecast | 19.71 |
| 2nd UP Forecast | 15.54 |
| 1st UP Forecast | 11.37 |
| 1st DOWN Forecast | -0.53 |
| 2nd DOWN Forecast | -4.7 |
| 3rd DOWN Forecast | -8.87 |
| 4th DOWN Forecast | -15.62 |
Prelude Therapeutics Incorporated ( NASDAQ USA Symbol : PRLD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PRLD Business Profile
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of small molecule therapies optimized to target the key driver mechanisms in cancers. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies in patients who are refractory to or intolerant of established therapies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme and primary central nervous system lymphomas. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; and PRT-K4 that is in preclinical stage for solid tumors. Prelude Therapeutics Incorporated was incorporated in 2016 and is headquartered in Wilmington, Delaware. Address: 200 Powder Mill Road, Wilmington, DE, United States, 19803
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service